Dupilumab elicits a favorable response in type-2 inflammatory comorbidities of severe atopic dermatitis

BACKGROUND: This case is the first report describing rapid, successful treatment of severe atopic dermatitis (AD) and comorbid type-2 inflammatory diseases in the same patient, with dupilumab treatment, with no side-effects. CASE PRESENTATION: We report on effects of dupilumab in a patient with seve...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Mol Allergy
Auteurs principaux: Nettis, Eustachio, Masciopinto, Lucia, Di Leo, Elisabetta, De Candia, Nicola, Albanesi, Marcello, Di Bona, Danilo, Quaranta, Nicola, Macchia, Luigi
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2021
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8207639/
https://ncbi.nlm.nih.gov/pubmed/34134707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12948-021-00144-x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires